Differences in CD33 intensity between various myeloid neoplasmsJILANI, Iman; ESTEY, Elihu; KEATING, Michael et al.American journal of clinical pathology. 2002, Vol 118, Num 4, pp 560-566, issn 0002-9173Article

A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expressionGILES, Francis J; NEBIYOU BEKELE, B; THALL, Peter et al.British journal of haematology. 2003, Vol 121, Num 4, pp 578-585, issn 0007-1048, 8 p.Article

Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphomaKHOURY, Joseph D; JONES, Dan; YARED, Marwan A et al.The American journal of surgical pathology. 2004, Vol 28, Num 4, pp 489-495, issn 0147-5185, 7 p.Article

Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK⁺ and ALK^- anaplastic large cell lymphomaKHOURY, Joseph D; MEDEIROS, L. Jeffrey; RASSIDAKIS, George Z et al.Clinical cancer research. 2003, Vol 9, Num 10, pp 3692-3699, issn 1078-0432, 8 p., 1Article